QA: Spotlight Innovation Inc in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001388486_2018_Spotlight_Innovation_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Similarly named company. Duplicate? None {'details': [{'other_company': 'Innovation Pharmaceuticals Inc', 'shared_tokens': {'innovation'}}]}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001388486, Spotlight Innovation Inc

  xvar xval
0 AssetsCurrent 262,856
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,033
3 remainder_Assets 6,977,347
4 LiabilitiesCurrent 2,693,086
5 LiabilitiesNoncurrent 1,243,716
6 remainder_Liabilities 2,564,226
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 3,759,173
9 ResearchAndDevelopmentExpense 742,118
10 remainder_Expenses 131,617
11 remainder_Revenues 2,226
12 remainder_NetIncome -1,539,181
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 7,249,236
1 Liabilities 6,501,028
2 Expenses 4,632,908
3 Revenues 2,226
4 StockholdersEquity 748,208
5 NetIncome -6,169,863
6 ComprehensiveNetIncome -6,169,863
7 BaseVar 9,962,290
8 EconomicCapitalRatiobeforeLimitedLiability -0.660
9 EconomicCapitalRatio 1.36

Edgar->Model Mapping

Feature Distribution

Change over Time